1229 control of graft versus host disease using a chimeric suicide gene

1229 Control of Graft Versus Host Disease Using a Chimeric Suicide Gene Molecular Therapy Vol 5, No 5, May 2002, Part 2 of 2 Parts Copyright © The American Society of Gene Therapy S399 ����"��� �"����[.]

Molecular Therapy Vol 5, No 5, May 2002, Part 2 of 2 Parts

" " "

1226 The Developmental Potential of a Single Adult

Hematopoietic Stem Cell

Fernando D Camargo, 1 Margaret A Goodell 1

1 Program in Cell and Molecular Biology and Center for Cell and

Gene Therapy, Baylor College of Medicine, Houston, TX, United

States.



 " "   "

1227 Effect of Neutralizing Antibodies on Adenovirus

Gene Delivery by the Intravenous Route of

Administration: T

Administration: Translational Model for Human Immune ranslational Model for Human Immune

Response to Adenovirus

Van Tsai, 1 Amena Rahman, 2 Drake LaFace, 1 Monica Zepeda, 1 Shu

Fen Wen, 1 Robert Ralston, 1 Dan Maneval 1

1 Canji Inc, San Diego, CA, United States; 2 GenStar Therapeutics,

San Diego, CA, United States.

1228 Characterization and Modulation of the Undesirable T Cell-Mediated Responses to T Undesirable T Cell-Mediated Responses to Transgenes ransgenes

Maria-Grazia Roncarolo, 1 Megan K Levings, 1 Patrizia Mangia, 2 Claudio Bordignon, 1,2 Sarah Marktel, 1 Chiara Bonini, 2 Catia Traversari 2,3

1 San Raffaele Telethon Institute for Gene Therapy, Scientific Institute H San Raffaele, Milan, Italy; 2 Cancer Immunotherapy and Gene Therapy Program, Scientific Institute H San Raffaele, Milan, Italy; 3 MolMed SpA, Scientific Institute H San Raffaele, Milan, Italy.

1229 Control of Graft-V

1229 Control of Graft-Versus-Host Disease Using a ersus-Host Disease Using a Chimeric Suicide Gene

Michael P Rettig, Julie K Ritchey, John F DiPersio.

Molecular Therapy Vol 5, No 5, May 2002, Part 2 of 2 Parts Copyright © The American Society of Gene Therapy

S400

" " "

 -C",

,389 B    &389 &

B

&

&

B

1230. Ex V Ex Vivo ivo ivo Gene T Gene T Gene Transfer into Human L ransfer into Human L ransfer into Human Lymphoid ymphoid

Progenitors Results in In Vivo In Vivo Functionally Mature Functionally Mature

T

Transduced T and B Cells ransduced T and B Cells

Francesca Ficara, 1 Alessandro Aiuti, 1 Cristina Mocchetti, 1 Daniela

Superchi, 1 Nicole Carballido, 2 Sara Deola, 1 José Carballido, 2 Maria

Grazia Roncarolo 1

1 Telethon Institute for Gene Therapy, Scientific Institute

H.S.Raffaele, Milan, Italy; 2 Novartis Research Institute, Vienna,

Austria.

J

J

$=6 J

J %=: 

J

J

$=6 J

J

1231 Induction of T Cell T

1231 Induction of T Cell Tolerance to a MHC Class I olerance to a MHC Class I Alloantigen by Gene Therapy

Jessamyn Bagley, 1 Chaorui Tian, 1 David H Sachs, 1 John Iacomini 1

1 Transplantation Biology Research Center, Massachusetts General Hospital, Boston, Massachusetts, United States.



0 - 0 4



289#2@->),?  - 0 4/ 

8 J

,? 





1232 Engraftment of EGFP-Expressing Bone Marrow

in Non-Myeloablatively Conditioned Recipients Results in Immunological T

Immunological Tolerance towards EGFP-T olerance towards EGFP-T olerance towards EGFP-Transgenic Skin ransgenic Skin Grafts

Goran Andersson, 1 Maria Denaro, 1 Kevin Johnson, 1 Peter Morgan, 1 Angela Sullivan, 1 David Calderhead, 1 Stuart Houser, 2 Clive Patience, 1 Mary White-Scharf, 1 Julian Down 1

1 Biotransplant Incorporated, Boston, MA, United States;

2 Transplantation Biology Research Center, Massachusetts General Hospital, Boston, MA, United States.